Organon today announced that Obstetrics & Gynecology, the peer-reviewed journal of the American College of Obstetrics and Gynecology (ACOG), published the results of the RUBY study which reached its primary effectiveness outcome of successfully treating abnormal postpartum uterine bleeding and postpartum hemorrhage with the JADA® System.
JADA Rapidly and Effectively Controlled Bleeding Due to PPH,1 Reinforcing Pivotal Study Results1PPH is a Significant Cause of Maternal Morbidities in the U.S.2,3,4,5New Exploratory Post-Hoc Analysis Examined the Relationship Between Reported Severe Maternal Morbidity (SMM) Outcomes and Cumulative Blood Loss Prior to.
14.09.2023 - Organon (NYSE: OGN), a global healthcare company focused on improving women’s health, today announced that Obstetrics & Gynecology (“The Green Journal”), the peer-reviewed journal of the American College of Obstetrics and Gynecology (ACOG), .
JADA Rapidly and Effectively Controlled Bleeding Due to PPH,1 Reinforcing Pivotal Study Results1
PPH is a Significant Cause of Maternal Morbidities in the U.S.2,3,4,5
New Exploratory Post-Hoc.